Clinical Trial Update: A Study Comparing the Efficacy and Safety Between I-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing I-CHOP versus R-CHOP in untreated CD20-positive diffuse large B-cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• I-CHOP
• R-CHOP

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Diffuse, Large B-Cell, Lymphoma | Phase 3 | Status: COMPLETED